Modulation of the poliovirus receptor function

Details for Australian Patent Application No. 2004213150 (hide)

Owner Xerion Pharmaceuticals AG Tufts University

Inventors Jay, Daniel G.; Eustace, Brenda K.; Torella, Claudia; Zehetmeier, Carolin; Sloan, Kevin Ernest; Unger, Christine Margarete; Beste, Gerald; Lain, Blanca

Agent Pipers

Pub. Number AU-A-2004213150

PCT Pub. Number WO2004/074324

Priority 60/450,064 24.02.03 US; 03 012 314.5 28.05.03 EP

Filing date 19 February 2004

Wipo publication date 2 September 2004

International Classifications

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 035/00 Antineoplastic agents

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

G01N 033/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 031/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/074324 Priority application(s): WO2004/074324

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213151-Metallized opaque film

2004213149-Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates